Residential sales in Hong Kong continue to improve, and mainland China sales are on track, embattled company says.

China announced plans on Thursday to channel hundreds of billions of yuan of investment from state-owned insurers into shares as part of the government's latest efforts to support a struggling stock market.

Hong Kong shareholders of Shanghai Henlius Biotech on Wednesday rejected Chinese conglomerate Fosun International's buyout offer, which would have valued the drugmaker at HK$13.37 billion ($1.72 billion).

HONG KONG -- The historic legislation for Basic Law Article 23, aimed at safeguarding national security and ensuring Hong Kong's stability and development, has topped a list of the ten most significant policies by the Hong Kong Special Administrative Region (HKSAR) government in 2024.

Asian equities were higher, except for Hong Kong and Mainland China, which were off following President Trump’s 10% tariff threat, which prompted profit-taking after six days of gains.

The Company makes available through the Investor Relations section of its internet website at http://ir.yumchina.com its filings with the HKEX as soon as reasonably practicable after electronically filing such materials with the HKEX. These filings may also be obtained by visiting the HKEX's website at http://www.hkex.com.hk.

The Chinese government is trying to encourage people to spend more by ensuring that share prices will rise, ordering pensions and mutual funds to invest more in domestic stock markets

U.S.-based Prolium Biosciences has now agreed to pay InnoCare and Keymed $17.5 million in upfront and near-term payments to develop and commercialize ICP-B02 as a cancer drug outside of China. Prolium also has the right to develop ICP-B02 in non-cancer indications globally, according to a filling with the Hong Kong Stock Exchange (PDF).

US President Donald Trump had threatened 60% tariffs on Chinese goods on his campaign trail.

The Hong Kong stock market has finished higher in six straight sessions, rallying more than 1,230 points or 6 percent in that span.

Asia-Pacific markets were set to open higher Monday, ahead of Donald Trump's inauguration with investors awaiting greater clarity on the policies of the incoming U.S. administration. Australia's S&P/ASX 200 rose 0.2% at the open.